Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 2.44 is in line with its 2-year average of 2.46, around the middle of its 2-year range (0.00–6.78).
As of the fiscal period ended Tuesday, June 30, 2026. 19.12% below its 12-month average of 3.01.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.44.
QUICK RATIO (ACID-TEST)
2.44
QUICK RATIO (ACID-TEST) AVG TTM
3.01
QUICK RATIO (ACID-TEST) AVG 3Y
N/A
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-19.12%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 563 covered companies
CURRENT VS SECTOR MEDIAN
-18.46%
vs the sector median at left
CapsoVision, Inc.
Market Cap
$323.01M
Quick Ratio (Acid-Test)
2.44
TTM Avg
3.01
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$328.40M
Quick Ratio (Acid-Test)
5.45
TTM Avg
6.76
3Y Avg
6.92
5Y Avg
7.12
Market Cap
$329.37M
Quick Ratio (Acid-Test)
5.79
TTM Avg
4.46
3Y Avg
8.92
5Y Avg
12.08
Market Cap
$316.53M
Quick Ratio (Acid-Test)
12.80
TTM Avg
4.01
3Y Avg
4.01
5Y Avg
4.01
Market Cap
$309.45M
Quick Ratio (Acid-Test)
8.80
TTM Avg
4.55
3Y Avg
3.67
5Y Avg
2.92
Market Cap
$304.88M
Quick Ratio (Acid-Test)
34.00
TTM Avg
44.34
3Y Avg
25.02
5Y Avg
19.51
Market Cap
$341.46M
Quick Ratio (Acid-Test)
3.87
TTM Avg
3.84
3Y Avg
4.42
5Y Avg
6.10
Market Cap
$341.50M
Quick Ratio (Acid-Test)
24.16
TTM Avg
12.00
3Y Avg
8.65
5Y Avg
7.93
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CapsoVision, Inc. (CV) | $323.01M | 2.44 | 3.01 | N/A | N/A |
| C4 Therapeutics, Inc. (CCCC)vs › | $328.40M | 5.45 | 6.76 | 6.92 | 7.12 |
| Cabaletta Bio, Inc. (CABA)vs › | $329.37M | 5.79 | 4.46 | 8.92 | 12.08 |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $316.53M | 12.80 | 4.01 | 4.01 | 4.01 |
| Standard BioTools Inc. (LAB)vs › | $309.45M | 8.80 | 4.55 | 3.67 | 2.92 |
| Benitec Biopharma Inc. (BNTC)vs › | $304.88M | 34.00 | 44.34 | 25.02 | 19.51 |
| ClearPoint Neuro, Inc. (CLPT)vs › | $341.46M | 3.87 | 3.84 | 4.42 | 6.10 |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $341.50M | 24.16 | 12.00 | 8.65 | 7.93 |
| Agenus Inc. (AGEN)vs › | $348.55M | 0.34 | 0.31 | 0.53 | 0.83 |
| Embecta Corp. (EMBC)vs › | $354.48M | 1.68 | 1.66 | 1.70 | 1.47 |
Quick Ratio
2.44
Excludes inventory
Current Ratio
3.35
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 2.44 |
| 2026-03-31 | 3.92 |
| 2025-12-31 | 3.09 |
| 2025-09-30 | 4.50 |
| 2025-06-30 | 1.13 |
| 2025-03-31 | 2.76 |
| 2024-12-31 | 6.78 |
| 2024-09-30 | 0.00 |
| 2024-06-30 | 0.00 |
| 2024-03-31 | 0.00 |
